Trial Outcomes & Findings for Independent Walking for Brain Health (NCT NCT03058146)
NCT ID: NCT03058146
Last Updated: 2023-07-17
Results Overview
Average minutes per day spent in moderate to vigorous levels of physical activity (MVPA) (defined as =\>1952 accelerometer counts per minute). MVPA minutes were determined based on one-week of accelerometer wear on the hip at baseline and post intervention.
TERMINATED
NA
53 participants
Pre (baseline) and post (3 months)
2023-07-17
Participant Flow
Participants were recruited from ongoing studies at the University of California San Diego and the Shiley-Marcos Alzheimer's Disease Research Center, as well as from ResearchMatch, flyers, community engagement talks (ie, talks at retirement communities, senior centers, libraries, and health fairs) and by word of mouth. All participants were enrolled between October 2017 and March 2020, at which time study recruitment was terminated because of the COVID-19 pandemic.
53 participants were enrolled (signed informed consent). After enrollment, 7 did not meet further eligibility criteria (based on cognitive and fitness testing) and 2 did not complete the baseline sessions due to the COVID-19 shut down. Out of 53 enrolled, 44 were randomized to the exercise (n=21) and control conditions (n=23). One participant randomized to the control condition could not start the intervention due to the COVID-19 shut down. Total analytic sample is N=43 (exercise=21,control=22).
Participant milestones
| Measure |
Physical Activity Condition
Physically inactive older adults in this condition will perform 3 months of prescribed brisk walking (to increase cardio respiratory fitness) in their real world environments, using mobile health (mHealth) devices during each exercise session to achieve and maintain a minimum of 150 minutes of moderate to vigorous physical activity (MVPA) per week.
|
Healthy Aging Education Condition
The education control condition will provide participants with materials and homework assignments on issues related to successful aging, such as nutrition, healthcare, and the typical changes associated with aging.
|
|---|---|---|
|
Overall Study
STARTED
|
21
|
23
|
|
Overall Study
COMPLETED
|
17
|
21
|
|
Overall Study
NOT COMPLETED
|
4
|
2
|
Reasons for withdrawal
| Measure |
Physical Activity Condition
Physically inactive older adults in this condition will perform 3 months of prescribed brisk walking (to increase cardio respiratory fitness) in their real world environments, using mobile health (mHealth) devices during each exercise session to achieve and maintain a minimum of 150 minutes of moderate to vigorous physical activity (MVPA) per week.
|
Healthy Aging Education Condition
The education control condition will provide participants with materials and homework assignments on issues related to successful aging, such as nutrition, healthcare, and the typical changes associated with aging.
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
4
|
1
|
|
Overall Study
Coronavirus (COVID)-19 shutdown
|
0
|
1
|
Baseline Characteristics
Independent Walking for Brain Health
Baseline characteristics by cohort
| Measure |
Physical Activity Condition
n=21 Participants
Physically inactive older adults in this condition will perform 3 months of prescribed brisk walking (to increase cardio respiratory fitness) in their real world environments, using mobile health (mHealth) devices during each exercise session to achieve and maintain a minimum of 150 minutes of moderate to vigorous physical activity (MVPA) per week.
|
Healthy Aging Education Condition
n=22 Participants
The education control condition will provide participants with materials and homework assignments on issues related to successful aging, such as nutrition, healthcare, and the typical changes associated with aging.
|
Total
n=43 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
71.24 years
STANDARD_DEVIATION 4.27 • n=5 Participants
|
72.27 years
STANDARD_DEVIATION 4.14 • n=7 Participants
|
71.77 years
STANDARD_DEVIATION 4.19 • n=5 Participants
|
|
Sex: Female, Male
Female
|
16 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
32 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
16 Participants
n=5 Participants
|
21 Participants
n=7 Participants
|
37 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
3 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
18 Participants
n=5 Participants
|
22 Participants
n=7 Participants
|
40 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
21 participants
n=5 Participants
|
22 participants
n=7 Participants
|
43 participants
n=5 Participants
|
|
Baseline MVPA
|
26.37 Average MVPA minutes per day
STANDARD_DEVIATION 17.31 • n=5 Participants
|
21.32 Average MVPA minutes per day
STANDARD_DEVIATION 17.42 • n=7 Participants
|
23.8 Average MVPA minutes per day
STANDARD_DEVIATION 17.36 • n=5 Participants
|
PRIMARY outcome
Timeframe: Pre (baseline) and post (3 months)Population: All participants who were randomized and completed the baseline sessions were included in the analyses (N=43).
Average minutes per day spent in moderate to vigorous levels of physical activity (MVPA) (defined as =\>1952 accelerometer counts per minute). MVPA minutes were determined based on one-week of accelerometer wear on the hip at baseline and post intervention.
Outcome measures
| Measure |
Physical Activity Condition
n=21 Participants
Physically inactive older adults in this condition will perform 3 months of prescribed brisk walking (to increase cardio respiratory fitness) in their real world environments, using mobile health (mHealth) devices during each exercise session to achieve and maintain a minimum of 150 minutes of moderate to vigorous physical activity (MVPA) per week.
|
Healthy Aging Education Condition
n=22 Participants
The education control condition will provide participants with materials and homework assignments on issues related to successful aging, such as nutrition, healthcare, and the typical changes associated with aging.
|
|---|---|---|
|
Moderate to Vigorous Physical Activity (MVPA) Average Per Day
Pre MVPA average minutes per day
|
26.37 average minutes per day
Standard Deviation 17.31
|
21.34 average minutes per day
Standard Deviation 17.44
|
|
Moderate to Vigorous Physical Activity (MVPA) Average Per Day
Post MVPA average minutes per day
|
44.09 average minutes per day
Standard Deviation 25.28
|
25.28 average minutes per day
Standard Deviation 15.99
|
SECONDARY outcome
Timeframe: Pre (baseline) and post (3 months)Population: We provide descriptive statistics for pre and post cerebral blood flow in the hippocampus and frontal cortex.
Average cerebral blood flow measured with arterial spin labeling magnetic resonance imaging in ml/100g/min. Cerebral blood flow was obtained via arterial spin labeling MRI and Freesurfer software was utilized to delineate regions of interest for each participant (right and left regions were averaged). For the frontal lobe cerebral blood flow we averaged the mean of superior frontal, rostral and caudal middle frontal, pars opercularis, pars triangularis, pars orbitalis, lateral and medial orbitofrontal, precentral, paracentral, and frontal pole.
Outcome measures
| Measure |
Physical Activity Condition
n=21 Participants
Physically inactive older adults in this condition will perform 3 months of prescribed brisk walking (to increase cardio respiratory fitness) in their real world environments, using mobile health (mHealth) devices during each exercise session to achieve and maintain a minimum of 150 minutes of moderate to vigorous physical activity (MVPA) per week.
|
Healthy Aging Education Condition
n=22 Participants
The education control condition will provide participants with materials and homework assignments on issues related to successful aging, such as nutrition, healthcare, and the typical changes associated with aging.
|
|---|---|---|
|
Cerebral Blood Flow (Hippocampal and Frontal)
Pre hippocampal cerebral blood flow
|
40.4 ml/100g/minute
Standard Deviation 10.82
|
41.03 ml/100g/minute
Standard Deviation 12.24
|
|
Cerebral Blood Flow (Hippocampal and Frontal)
Post hippocampal cerebral blood flow
|
35.36 ml/100g/minute
Standard Deviation 5.56
|
40.99 ml/100g/minute
Standard Deviation 9.1
|
|
Cerebral Blood Flow (Hippocampal and Frontal)
Post frontal cerebral blood flow
|
41.31 ml/100g/minute
Standard Deviation 7.41
|
46.96 ml/100g/minute
Standard Deviation 10.7
|
|
Cerebral Blood Flow (Hippocampal and Frontal)
Pre frontal cerebral blood flow
|
45.52 ml/100g/minute
Standard Deviation 11.58
|
47.24 ml/100g/minute
Standard Deviation 10.46
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Pre (baseline) and post (3 months)Population: All participants completed neuropsychological testing at pre and post.
A memory composite score was created by converting raw scores into z-scores and then averaging them for the following tests: Rey Auditory Verbal Learning Test trials 1 to 5, trial 6 (short-delay free recall), and delayed recall; Wechsler Memory Scale - Revised Logical Memory I and II (immediate and delayed recall scores). Z-scores were calculated using raw scores for these tests in the entire sample \[(raw score-mean of the sample)/standard deviation of the sample\]. Z-scores of 0 represent the sample's mean performance on the tests, z-scores \>0 indicate better performance compared to the sample's mean, while z-scores \<0 indicate worse performance compared to the sample's mean.
Outcome measures
| Measure |
Physical Activity Condition
n=21 Participants
Physically inactive older adults in this condition will perform 3 months of prescribed brisk walking (to increase cardio respiratory fitness) in their real world environments, using mobile health (mHealth) devices during each exercise session to achieve and maintain a minimum of 150 minutes of moderate to vigorous physical activity (MVPA) per week.
|
Healthy Aging Education Condition
n=22 Participants
The education control condition will provide participants with materials and homework assignments on issues related to successful aging, such as nutrition, healthcare, and the typical changes associated with aging.
|
|---|---|---|
|
Memory Function
Pre memory score
|
.08 z-score
Standard Deviation .8
|
-.07 z-score
Standard Deviation .82
|
|
Memory Function
Post memory score
|
-.10 z-score
Standard Deviation .94
|
.09 z-score
Standard Deviation .68
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Pre (baseline) and post (3 months)Population: All participants were included and descriptive statistics are presented for pre and post.
An executive function composite score was created by converting raw scores into z-scores and then averaging them for the following tests: Trail Making Test Part B minus Trail Making Test Part A, Golden version of the Stroop Color Word Trial, and verbal fluency (letters F,A,S). Trail making test scores were reversed prior to averaging, so higher scores = better performance. Z-scores were calculated using raw scores for these tests in the entire sample \[(raw score-mean of the sample)/standard deviation of the sample\]. Z-scores of 0 represent the sample's mean performance on the tests, z-scores \>0 indicate better performance compared to the sample's mean, while z-scores \<0 indicate worse performance compared to the sample's mean.
Outcome measures
| Measure |
Physical Activity Condition
n=21 Participants
Physically inactive older adults in this condition will perform 3 months of prescribed brisk walking (to increase cardio respiratory fitness) in their real world environments, using mobile health (mHealth) devices during each exercise session to achieve and maintain a minimum of 150 minutes of moderate to vigorous physical activity (MVPA) per week.
|
Healthy Aging Education Condition
n=22 Participants
The education control condition will provide participants with materials and homework assignments on issues related to successful aging, such as nutrition, healthcare, and the typical changes associated with aging.
|
|---|---|---|
|
Executive Function
Pre executive function score
|
.15 z-score
Standard Deviation .69
|
-.14 z-score
Standard Deviation .80
|
|
Executive Function
Post executive function score
|
.07 z-score
Standard Deviation .73
|
-.06 z-score
Standard Deviation .84
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Pre (baseline) and post (3 months)Population: Descriptive data are presented for pre and post.
Total time it takes the participant to reach 85% of their estimated maximal heart rate (220-age) measured via sub-maximal treadmill test in seconds.
Outcome measures
| Measure |
Physical Activity Condition
n=21 Participants
Physically inactive older adults in this condition will perform 3 months of prescribed brisk walking (to increase cardio respiratory fitness) in their real world environments, using mobile health (mHealth) devices during each exercise session to achieve and maintain a minimum of 150 minutes of moderate to vigorous physical activity (MVPA) per week.
|
Healthy Aging Education Condition
n=22 Participants
The education control condition will provide participants with materials and homework assignments on issues related to successful aging, such as nutrition, healthcare, and the typical changes associated with aging.
|
|---|---|---|
|
Cardiorespiratory Fitness
Pre cardiorespiratory fitness (seconds)
|
873.48 seconds
Standard Deviation 175.47
|
840.55 seconds
Standard Deviation 277.62
|
|
Cardiorespiratory Fitness
Post cardiorespiratory fitness (seconds)
|
995.71 seconds
Standard Deviation 157.43
|
948.61 seconds
Standard Deviation 172.52
|
Adverse Events
Physical Activity Condition
Healthy Aging Education Condition
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Physical Activity Condition
n=21 participants at risk
Physically inactive older adults in this condition will perform 3 months of prescribed brisk walking (to increase cardio respiratory fitness) in their real world environments, using mobile health (mHealth) devices during each exercise session to achieve and maintain a minimum of 150 minutes of moderate to vigorous physical activity (MVPA) per week.
|
Healthy Aging Education Condition
n=22 participants at risk
The education control condition will provide participants with materials and homework assignments on issues related to successful aging, such as nutrition, healthcare, and the typical changes associated with aging.
|
|---|---|---|
|
Renal and urinary disorders
Non serious adverse event
|
4.8%
1/21 • Number of events 1 • 12 weeks
Adverse events recording followed the National Institute on Aging (NIA) Adverse Event and Serious Adverse Event Guidelines as outlined by the study's Data and Safety Monitoring Plan (DSMP), which included a safety officer. All adverse events were carefully monitored via telephone contact throughout the trial and were reported to the Institutional Review Board (IRB) of the University of California, San Diego, and the NIA program official following National Institutes of Health (NIH) guidelines.
|
0.00%
0/22 • 12 weeks
Adverse events recording followed the National Institute on Aging (NIA) Adverse Event and Serious Adverse Event Guidelines as outlined by the study's Data and Safety Monitoring Plan (DSMP), which included a safety officer. All adverse events were carefully monitored via telephone contact throughout the trial and were reported to the Institutional Review Board (IRB) of the University of California, San Diego, and the NIA program official following National Institutes of Health (NIH) guidelines.
|
|
Eye disorders
Non serious adverse event
|
4.8%
1/21 • Number of events 1 • 12 weeks
Adverse events recording followed the National Institute on Aging (NIA) Adverse Event and Serious Adverse Event Guidelines as outlined by the study's Data and Safety Monitoring Plan (DSMP), which included a safety officer. All adverse events were carefully monitored via telephone contact throughout the trial and were reported to the Institutional Review Board (IRB) of the University of California, San Diego, and the NIA program official following National Institutes of Health (NIH) guidelines.
|
0.00%
0/22 • 12 weeks
Adverse events recording followed the National Institute on Aging (NIA) Adverse Event and Serious Adverse Event Guidelines as outlined by the study's Data and Safety Monitoring Plan (DSMP), which included a safety officer. All adverse events were carefully monitored via telephone contact throughout the trial and were reported to the Institutional Review Board (IRB) of the University of California, San Diego, and the NIA program official following National Institutes of Health (NIH) guidelines.
|
|
Musculoskeletal and connective tissue disorders
Non serious adverse event
|
4.8%
1/21 • Number of events 1 • 12 weeks
Adverse events recording followed the National Institute on Aging (NIA) Adverse Event and Serious Adverse Event Guidelines as outlined by the study's Data and Safety Monitoring Plan (DSMP), which included a safety officer. All adverse events were carefully monitored via telephone contact throughout the trial and were reported to the Institutional Review Board (IRB) of the University of California, San Diego, and the NIA program official following National Institutes of Health (NIH) guidelines.
|
0.00%
0/22 • 12 weeks
Adverse events recording followed the National Institute on Aging (NIA) Adverse Event and Serious Adverse Event Guidelines as outlined by the study's Data and Safety Monitoring Plan (DSMP), which included a safety officer. All adverse events were carefully monitored via telephone contact throughout the trial and were reported to the Institutional Review Board (IRB) of the University of California, San Diego, and the NIA program official following National Institutes of Health (NIH) guidelines.
|
|
Social circumstances
Non serious adverse event
|
0.00%
0/21 • 12 weeks
Adverse events recording followed the National Institute on Aging (NIA) Adverse Event and Serious Adverse Event Guidelines as outlined by the study's Data and Safety Monitoring Plan (DSMP), which included a safety officer. All adverse events were carefully monitored via telephone contact throughout the trial and were reported to the Institutional Review Board (IRB) of the University of California, San Diego, and the NIA program official following National Institutes of Health (NIH) guidelines.
|
4.5%
1/22 • Number of events 1 • 12 weeks
Adverse events recording followed the National Institute on Aging (NIA) Adverse Event and Serious Adverse Event Guidelines as outlined by the study's Data and Safety Monitoring Plan (DSMP), which included a safety officer. All adverse events were carefully monitored via telephone contact throughout the trial and were reported to the Institutional Review Board (IRB) of the University of California, San Diego, and the NIA program official following National Institutes of Health (NIH) guidelines.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place